
Sign up to save your podcasts
Or
Interview with David W. Hutton, PhD, author of Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema. Hosted by Neil Bressler, MD.
4
55 ratings
Interview with David W. Hutton, PhD, author of Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema. Hosted by Neil Bressler, MD.
131 Listeners
32 Listeners
493 Listeners
44 Listeners
37 Listeners
99 Listeners
17 Listeners
8 Listeners
17 Listeners
19 Listeners
14 Listeners
11 Listeners
7 Listeners
9 Listeners
21 Listeners
87 Listeners
11 Listeners
5 Listeners
29 Listeners
15 Listeners
5 Listeners
1 Listeners
106 Listeners
21 Listeners
3 Listeners
21 Listeners
10 Listeners
49 Listeners
10 Listeners
162 Listeners
17 Listeners
16 Listeners
16 Listeners
0 Listeners